Covaxin's safety, validated through rigorous trials and government evaluation, stands firm amidst global concerns over vaccine side effects. Bharat Biotech's proactive approach underscores its commitment to patient safety, with continuous monitoring ensuring a robust safety record. Amidst ongoing debates, Covaxin remains a beacon of reliability and effectiveness in India's vaccination efforts.